Cargando…

Hypercholesterolemia and microvascular dysfunction: interventional strategies

Hypercholesterolemia is defined as excessively high plasma cholesterol levels, and is a strong risk factor for many negative cardiovascular events. Total cholesterol levels above 200 mg/dl have repeatedly been correlated as an independent risk factor for development of peripheral vascular (PVD) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Stapleton, Phoebe A, Goodwill, Adam G, James, Milinda E, Brock, Robert W, Frisbee, Jefferson C
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996379/
https://www.ncbi.nlm.nih.gov/pubmed/21087503
http://dx.doi.org/10.1186/1476-9255-7-54
_version_ 1782193197283278848
author Stapleton, Phoebe A
Goodwill, Adam G
James, Milinda E
Brock, Robert W
Frisbee, Jefferson C
author_facet Stapleton, Phoebe A
Goodwill, Adam G
James, Milinda E
Brock, Robert W
Frisbee, Jefferson C
author_sort Stapleton, Phoebe A
collection PubMed
description Hypercholesterolemia is defined as excessively high plasma cholesterol levels, and is a strong risk factor for many negative cardiovascular events. Total cholesterol levels above 200 mg/dl have repeatedly been correlated as an independent risk factor for development of peripheral vascular (PVD) and coronary artery disease (CAD), and considerable attention has been directed toward evaluating mechanisms by which hypercholesterolemia may impact vascular outcomes; these include both results of direct cholesterol lowering therapies and alternative interventions for improving vascular function. With specific relevance to the microcirculation, it has been clearly demonstrated that evolution of hypercholesterolemia is associated with endothelial cell dysfunction, a near-complete abrogation in vascular nitric oxide bioavailability, elevated oxidant stress, and the creation of a strongly pro-inflammatory condition; symptoms which can culminate in profound impairments/alterations to vascular reactivity. Effective interventional treatments can be challenging as certain genetic risk factors simply cannot be ignored. However, some hypercholesterolemia treatment options that have become widely used, including pharmaceutical therapies which can decrease circulating cholesterol by preventing either its formation in the liver or its absorption in the intestine, also have pleiotropic effects with can directly improve peripheral vascular outcomes. While physical activity is known to decrease PVD/CAD risk factors, including obesity, psychological stress, impaired glycemic control, and hypertension, this will also increase circulating levels of high density lipoprotein and improving both cardiac and vascular function. This review will provide an overview of the mechanistic consequences of the predominant pharmaceutical interventions and chronic exercise to treat hypercholesterolemia through their impacts on chronic sub-acute inflammation, oxidative stress, and microvascular structure/function relationships.
format Text
id pubmed-2996379
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29963792010-12-03 Hypercholesterolemia and microvascular dysfunction: interventional strategies Stapleton, Phoebe A Goodwill, Adam G James, Milinda E Brock, Robert W Frisbee, Jefferson C J Inflamm (Lond) Review Hypercholesterolemia is defined as excessively high plasma cholesterol levels, and is a strong risk factor for many negative cardiovascular events. Total cholesterol levels above 200 mg/dl have repeatedly been correlated as an independent risk factor for development of peripheral vascular (PVD) and coronary artery disease (CAD), and considerable attention has been directed toward evaluating mechanisms by which hypercholesterolemia may impact vascular outcomes; these include both results of direct cholesterol lowering therapies and alternative interventions for improving vascular function. With specific relevance to the microcirculation, it has been clearly demonstrated that evolution of hypercholesterolemia is associated with endothelial cell dysfunction, a near-complete abrogation in vascular nitric oxide bioavailability, elevated oxidant stress, and the creation of a strongly pro-inflammatory condition; symptoms which can culminate in profound impairments/alterations to vascular reactivity. Effective interventional treatments can be challenging as certain genetic risk factors simply cannot be ignored. However, some hypercholesterolemia treatment options that have become widely used, including pharmaceutical therapies which can decrease circulating cholesterol by preventing either its formation in the liver or its absorption in the intestine, also have pleiotropic effects with can directly improve peripheral vascular outcomes. While physical activity is known to decrease PVD/CAD risk factors, including obesity, psychological stress, impaired glycemic control, and hypertension, this will also increase circulating levels of high density lipoprotein and improving both cardiac and vascular function. This review will provide an overview of the mechanistic consequences of the predominant pharmaceutical interventions and chronic exercise to treat hypercholesterolemia through their impacts on chronic sub-acute inflammation, oxidative stress, and microvascular structure/function relationships. BioMed Central 2010-11-18 /pmc/articles/PMC2996379/ /pubmed/21087503 http://dx.doi.org/10.1186/1476-9255-7-54 Text en Copyright ©2010 Stapleton et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Stapleton, Phoebe A
Goodwill, Adam G
James, Milinda E
Brock, Robert W
Frisbee, Jefferson C
Hypercholesterolemia and microvascular dysfunction: interventional strategies
title Hypercholesterolemia and microvascular dysfunction: interventional strategies
title_full Hypercholesterolemia and microvascular dysfunction: interventional strategies
title_fullStr Hypercholesterolemia and microvascular dysfunction: interventional strategies
title_full_unstemmed Hypercholesterolemia and microvascular dysfunction: interventional strategies
title_short Hypercholesterolemia and microvascular dysfunction: interventional strategies
title_sort hypercholesterolemia and microvascular dysfunction: interventional strategies
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996379/
https://www.ncbi.nlm.nih.gov/pubmed/21087503
http://dx.doi.org/10.1186/1476-9255-7-54
work_keys_str_mv AT stapletonphoebea hypercholesterolemiaandmicrovasculardysfunctioninterventionalstrategies
AT goodwilladamg hypercholesterolemiaandmicrovasculardysfunctioninterventionalstrategies
AT jamesmilindae hypercholesterolemiaandmicrovasculardysfunctioninterventionalstrategies
AT brockrobertw hypercholesterolemiaandmicrovasculardysfunctioninterventionalstrategies
AT frisbeejeffersonc hypercholesterolemiaandmicrovasculardysfunctioninterventionalstrategies